Skip to main content

Depressive Pseudodementia

Depressive Pseudodementia


Depressive pseudodementia is a condition that has been described as having cognitive impairment, memory loss, and other symptoms that mimic those of dementia, but are caused by depression instead of a degenerative brain disease. In this article, we will explore the current understanding of depressive pseudodementia, including its diagnosis, symptoms, and treatment.


Depressive pseudodementia is not a recognized diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is the standard diagnostic manual for mental health conditions. However, some experts believe that it is a useful concept for understanding the relationship between depression and cognitive impairment (1). To be diagnosed with depressive pseudodementia, a patient must have symptoms that resemble those of dementia, but the symptoms must be caused by depression rather than a degenerative brain disease (2).


The symptoms of depressive pseudodementia can include forgetfulness, confusion, difficulty concentrating, and problems with language and decision-making. These symptoms may be severe enough to interfere with daily activities and work, and may lead to a misdiagnosis of dementia. However, unlike dementia, which is a progressive and irreversible condition, the cognitive symptoms of depressive pseudodementia can be improved with appropriate treatment of the underlying depression (2).


Treatment for depressive pseudodementia typically involves psychotherapy and/or antidepressant medication. With proper treatment, the cognitive symptoms of the condition can be reversed, and patients can regain their cognitive functioning (3). However, early diagnosis is important, as delay in treatment can lead to a worsening of symptoms and decreased effectiveness of treatment (2).


In conclusion, depressive pseudodementia is a condition that is characterized by cognitive impairment that is caused by depression. While it is not a recognized diagnosis in the DSM-5, it is considered a useful concept by some experts. The condition can be effectively treated with psychotherapy and/or medication, and early diagnosis is important for a good prognosis.


  1. Aalten, P., van Valen, E., de Vugt, M. E., Lousberg, R., Jolles, J., Verhey, F. R., & Rozendaal, N. (2003). Awareness and behavioral problems in dementia patients: A prospective study. International psychogeriatrics, 15(4), 365-375.
  2. Steffens, D. C., Otey, E., Alexopoulos, G. S., Butters, M. A., Cuthbert, B., Ganguli, M., ... & Taylor, W. D. (2006). Perspectives on depression, mild cognitive impairment, and cognitive decline. Archives of general psychiatry, 63(2), 130-138.
  3. Sheline, Y. I. (2003). Depression and the hippocampus: cause or effect?. Biological psychiatry, 54(3), 201-202.


Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (

ICD-11 Criteria for Anorexia Nervosa (6B80)

ICD-11 Criteria for Anorexia Nervosa (6B80) Anorexia Nervosa is characterised by significantly low body weight for the individual’s height, age and developmental stage that is not due to another health condition or to the unavailability of food. A commonly used threshold is body mass index (BMI) less than 18.5 kg/m2 in adults and BMI-for-age under 5th percentile in children and adolescents. Rapid weight loss (e.g. more than 20% of total body weight within 6 months) may replace the low body weight guideline as long as other diagnostic requirements are met. Children and adolescents may exhibit failure to gain weight as expected based on the individual developmental trajectory rather than weight loss. Low body weight is accompanied by a persistent pattern of behaviours to prevent restoration of normal weight, which may include behaviours aimed at reducing energy intake (restricted eating), purging behaviours (e.g. self-induced vomiting, misuse of laxatives), and behaviours aimed at incr

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:               Adjustment disorder (6B43) Bipolar or related disorders (BlockL2‑6A6) Sing